Louis Lavoie
Overview
Explore the profile of Louis Lavoie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campbell J, Lavoie L, Farraia M, Huelin R, Zhang Q, Monfared A
Neurol Ther
. 2024 Nov;
14(1):7-26.
PMID: 39489884
Mild cognitive impairment (MCI) and Alzheimer's disease (AD) have a profound impact on patients' quality of life (QoL), with progressive declines occurring as the disease advances. This systematic review aims...
2.
Klekotka P, Lavoie L, Mitchell B, Iheanacho I, Burge R, Cohee A, et al.
Front Immunol
. 2024 Nov;
15:1425478.
PMID: 39483464
Introduction: Several current therapies for autoimmune diseases do not provide sustained remission. Therapies that focus on the restoration of homeostasis within the immune system (i.e., immune resolution) could overcome the...
3.
Drysdale M, Berktas M, Gibbons D, Rolland C, Lavoie L, Lloyd E
Infection
. 2024 Apr;
52(5):1839-1861.
PMID: 38602623
Purpose: To evaluate clinical outcomes associated with sotrovimab use during Omicron BA.2 and BA.5 predominance. Methods: Electronic databases were searched for observational studies published in peer-reviewed journals, preprint articles and...
4.
Drysdale M, Gibbons D, Singh M, Rolland C, Lavoie L, Skingsley A, et al.
Infection
. 2023 Sep;
52(1):1-17.
PMID: 37776474
Purpose: Emerging SARS-CoV-2 variants have impacted the in vitro activity of sotrovimab, with variable fold changes in neutralization potency for the Omicron BA.2 sublineage and onward. The correlation between reduced...
5.
Forbes C, Lavoie L, Satram S, Shen L, Thanawala V, Arizpe A, et al.
Expert Rev Anti Infect Ther
. 2023 Jun;
21(8):847-862.
PMID: 37322901
Introduction: Hepatitis B Virus (HBV) infection can progress to chronic HBV (CHB) disease, thereby increasing the risk of severe forms of liver disease (i.e. liver cirrhosis and hepatocellular carcinoma) and...
6.
Schnitzler A, Dince C, Freitag A, Iheanacho I, Fahrbach K, Lavoie L, et al.
Toxins (Basel)
. 2022 Nov;
14(11).
PMID: 36355984
Disabling limb spasticity can result from stroke, traumatic brain injury or other disorders causing upper motor neuron lesions such as multiple sclerosis. Clinical studies have shown that abobotulinumtoxinA (AboBoNT-A) therapy...
7.
Wagner M, Samaha D, Khoury H, ONeil W, Lavoie L, Bennetts L, et al.
Adv Ther
. 2017 Dec;
35(1):81-99.
PMID: 29270780
Introduction: Well- or moderately differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are often slow-growing, and some patients with unresectable, asymptomatic, non-functioning tumors may face the choice between watchful waiting (WW), or somatostatin...
8.
Lavoie L, Khoury H, Welner S, Briere J
Cardiovasc Ther
. 2016 Feb;
34(3):152-60.
PMID: 26915344
Background: Chronic heart failure (HF) or coronary artery disease (CAD) confers risk for thromboembolism and secondary adverse cardiac events (ACEs) (e.g., mortality, myocardial infarction, and stroke). When HF and CAD...
9.
Khoury H, Lavoie L, Welner S, Folkerts K
Cardiovasc Ther
. 2015 Dec;
34(2):115-24.
PMID: 26670723
Background: Patients with a history of a cardiovascular (CV) disease are at high risk of suffering secondary major adverse cardiac events (MACE), namely death, nonfatal myocardial infarction (MI), stroke, symptomatic...
10.
Wagner M, Lavoie L, Goetghebeur M
Can J Infect Dis Med Microbiol
. 2014 May;
25(2):87-94.
PMID: 24855476
Background: Clostridium difficile infection (CDI) represents a public health problem with increasing incidence and severity. Objective: To evaluate the clinical and economic consequences of vancomycin compared with fidaxomicin in the...